Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Xilio Therapeutics (XLO) Leases (2024 - 2025)

Xilio Therapeutics (XLO) has disclosed Leases for 2 consecutive years, with $4.0 million as the latest value for Q4 2025.

  • Quarterly Leases fell 13.69% to $4.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Dec 2025, down 13.69% year-over-year, with the annual reading at $4.0 million for FY2025, 13.69% down from the prior year.
  • Leases hit $4.0 million in Q4 2025 for Xilio Therapeutics, down from $4.1 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $5.0 million in Q1 2024 to a low of $4.0 million in Q4 2025.